BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6163453)

  • 21. Antagonism of estrogen-induced prolactin release by progesterone.
    Brann DW; Rao IM; Mahesh VB
    Biol Reprod; 1988 Dec; 39(5):1067-73. PubMed ID: 3219380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone decreases the concentration of hypothalamic and anterior pituitary estrogen receptors in ovariectomized rats.
    Blaustein JD; Brown TJ
    Brain Res; 1984 Jun; 304(2):225-36. PubMed ID: 6744041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dopamine agonists and antagonists on the binding of [3H]estradiol to its receptors in the anterior pituitary gland of male rats.
    Szijan I; Burdman JA; Alonso GE
    Endocrinology; 1985 Nov; 117(5):1742-8. PubMed ID: 4042961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for 5 alpha-androstane-3 beta, 17 beta-diol binding to the estrogen receptor in the cytosol from male rat pituitary.
    Thieulant ML; Samperez S; Jouan P
    Endocrinology; 1981 Apr; 108(4):1552-60. PubMed ID: 7472283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear translocation of the rat pituitary cytosol 17beta-estradiol receptor.
    Bieglmayer C; Pöckl E; Spona J; Adamiker D; Jettmar W
    FEBS Lett; 1977 Sep; 81(2):342-6. PubMed ID: 923805
    [No Abstract]   [Full Text] [Related]  

  • 26. Estrogen receptors in cultured rat uterine cells: induction of progesterone receptors in the absence of estrogen receptor processing.
    Kassis JA; Walent JH; Gorski J
    Endocrinology; 1986 Feb; 118(2):603-8. PubMed ID: 3943487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogens in vitro.
    Lieberman ME; Jordan VC; Fritsch M; Santos MA; Gorski J
    J Biol Chem; 1983 Apr; 258(8):4734-40. PubMed ID: 6833271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiestrogens are partial estrogen agonists for prolactin production in primary pituitary cultures.
    Martinez-Campos A; Amara JF; Dannies PS
    Mol Cell Endocrinol; 1986 Dec; 48(2-3):127-33. PubMed ID: 3803705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptors for 17beta-estradiol in prolactin-secreting rat pituitary cells.
    Haug E; Naess O; Gautvik KM
    Mol Cell Endocrinol; 1978 Oct; 12(1):81-95. PubMed ID: 569089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 5 alpha-dihydrotestosterone and dexamethasone on estrogen receptors of the anterior pituitary and uterus.
    Zamorano P; Steinsapir J; Mahesh VB
    Steroids; 1992 Jan; 57(1):18-26. PubMed ID: 1585389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of estradiol on estrogen receptor, progesterone receptor, and tyrosinase in hamster melanoma transplanted into athymic mice.
    Hitselberger MH; Schleicher RL; Beattie CW
    Cancer Res; 1988 Jul; 48(13):3720-7. PubMed ID: 3132319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The alpha 1-noradrenergic antagonist prazosin decreases the concentration of estrogen receptors in female rat hypothalamus.
    Blaustein JD
    Brain Res; 1987 Feb; 404(1-2):39-50. PubMed ID: 2882810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamic, pituitary and uterine cytoplasmic and nuclear oestrogen receptors and their relationship to the serum concentration of tamoxifen and its metabolite, 4-hydroxytamoxifen, in the ovariectomized rat.
    Bowman SP; Leake A; Morris ID
    J Endocrinol; 1982 Aug; 94(2):167-75. PubMed ID: 7108408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
    Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
    Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture.
    Nawata H; Chong MT; Bronzert D; Lippman ME
    J Biol Chem; 1981 Jul; 256(13):6895-902. PubMed ID: 7240250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A characterization of estrogen's influence on anterior pituitary androgen receptor: effect of bromocriptine treatment.
    Handa RJ; Rodriguez EW
    Neuroendocrinology; 1991 Jan; 53(1):12-9. PubMed ID: 2046857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actions and interactions of delta 5-androstene-3 beta, 17 beta-diol and 17 beta-estradiol in the immature rat uterus.
    van Doorn LG; Poortman J; Thijssen JH; Schwarz F
    Endocrinology; 1981 Apr; 108(4):1587-93. PubMed ID: 7472285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.